Table 2.
Characteristic | M (SD) or % (n) |
---|---|
Age, years | 62.9 (11.2) |
Gender, male | 86.2% (25) |
Race | |
White | 82.8% (24) |
Black | 13.8% (4) |
Other | 3.4% (1) |
Referral source | |
Primary care provider | 79.3% (23) |
Palliative care | 10.3% (3) |
Other | 10.3% (3) |
Opioid use disorder diagnosis, % yes | 3.4% (1) |
Urine drug toxicology in past 12 months, % yes | 65.5% (19) |
Health psychology, % with at least one appointment | 34.4% (10) |
Opioid medication recommendation at intake | |
Buprenorphine | 58.6% (17) |
Continued full agonist opioid | 31.0% (9) |
Other | 10.3% (3) |
Opioid medication at 30 days after intake | |
Buprenorphine | 48.3% (14) |
Continued full agonist opioid | 3.8% (11) |
Not on buprenorphine or full agonist opioid | 13.8% (4) |
M = mean; SD = standard deviation.